The influence of dolichol, dolichol esters, and dolichyl phosphate on phospholipid polymorphism and fluidity in model membranes.
The effect of dolichols, polyprenols, dolichol esterified with fatty acids, and dolichyl phosphate on the structure and fluidity of model membranes was studied using 31P NMR, small-angle x-ray scattering, differential scanning calorimetry, and freeze-fracture electron microscopy. These studies suggest that dolichol and dolichol derivatives destabilize unsaturated phosphatidylethanolamine containing bilayer structures and promote hexagonal II phase formation; high concentrations of dolichol induce lipid structures characterized by "isotropic" 31P NMR and particulate fracture faces; dolichol, contrary to cholesterol, has no effect on the thermotropic behavior of membranes consisting of phosphatidylcholine, while dolichyl-P incorporation abolishes the transition from the gel to liquid crystalline phase in 1,2-dimyristoyl-sn-glycero-3-phosphocholine; both dolichol and dolichyl-P increase the fatty acid fluidity in phosphatidylethanolamine mixtures; the effect of dolichol on bilayer structure and fluidity is more pronounced with increasing number of isoprene residues; dolichol esters are only soluble to a limited extent in the bilayer and segregates into domains at low concentrations; the results are consistent with a localization of dolichyl-P in which the phosphate group is oriented to the water interphase. The induction of hexagonal II phase by dolichyl-P may elicit the transmembrane movement of glycosylated lipid intermediate.
D002152:Calorimetry, Differential Scanning; D004224:Diterpenes / Q000494:pharmacology*; D004288:Dolichol Phosphates / Q000494:pharmacology*; D004286:Dolichols / Q000031:analogs & derivatives / Q000494:pharmacology*; D004952:Esters; D005227:Fatty Acids; D005614:Freeze Fracturing; D006801:Humans; D009682:Magnetic Resonance Spectroscopy; D008560:Membrane Fluidity; D008563:Membrane Lipids; D008567:Membranes, Artificial; D008854:Microscopy, Electron; D008958:Models, Molecular; D010743:Phospholipids; D011106:Polyisoprenyl Phosphates / Q000494:pharmacology*; D012542:Scattering, Radiation; D013729:Terpenes / Q000494:pharmacology*
D004224:Diterpenes; D004288:Dolichol Phosphates; D004286:Dolichols; D004952:Esters; D005227:Fatty Acids; D008563:Membrane Lipids; D008567:Membranes, Artificial; D010743:Phospholipids; D011106:Polyisoprenyl Phosphates; D013729:Terpenes; C028306:dolichol monophosphate